Cognitive Integrated Motor Training (CM) to Improve Gait and Balance and Reduce Falls in Older Adults With Mild Cognitive Impairment

NCT ID: NCT06719297

Last Updated: 2024-12-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-12-01

Study Completion Date

2027-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Problems with walking and balance are common in older adults with mild cognitive impairment. Walking and balance problems limit independence and increase risk for injuries due to falls. The purpose of this research study is to test the effectiveness of training that combines moving and thinking tasks, referred to as Personalized cognitive integrated sensorimotor virtual reality (VR)/mixed reality (MR) training on walking and balance ability. The study will also help to understand the changes in thinking ability and brain activity as a result of this training in older adults with mild cognitive impairment.

The study will evaluate the differences between two intervention groups (n=20 each): 1) personalized cognitive integrated sensorimotor VR/MR training (CM), and 3) standard of care (CTRL) on gait, balance, community ambulation, and cognitive functions, as well as underlying biomechanical and neurophysiological mechanisms to understand the changes due to CM.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mild Cognitive Impairment

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

older adults, mild cognitive impairment, gait, balance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Personalized cognitive-sensorimotor VR/MR training

Thinking task integrated walking and balance training program

Group Type EXPERIMENTAL

Personalized cognitive-sensorimotor VR/MR training

Intervention Type OTHER

Thinking task integrated walking and balance training program

Standard of Care

Standard walking and balance training

Group Type ACTIVE_COMPARATOR

Standard of Care

Intervention Type OTHER

Standard walking and balance training

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Personalized cognitive-sensorimotor VR/MR training

Thinking task integrated walking and balance training program

Intervention Type OTHER

Standard of Care

Standard walking and balance training

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Between the age of 65 and 85 years for older adults.
* Montreal Cognitive Assessment (MOCA), 17 \< MOCA \< 24
* Medical clearance will be obtained from my clinician. If participants physician is unavailable the study team clinician will provide the medical clearance.
* Adequate cognitive function to give informed consent, understand the training and instructions, use the device and give adequate feedback.
* Able to stand for 5 minutes.

Exclusion Criteria

* Body weight over 135 kgs.
* Uncontrolled or unstable seizure disorder.
* Severe joint contracture or spasticity of the ankle that limits passive range of motion as determined by the team.
* History of severe cardiac diseases such as myocardial infarction, coronary artery disease, cardiac arrhythmia, or congestive heart failure.
* Neuromuscular or neurological pathologies (e.g., spinal cord injury, stroke) that will interfere with ambulation.
* Uncontrolled or unstable orthostatic hypotension.
* Pre-existing conditions resulting in significant disruption in alignment or function of the lower limb during standing.
* History of injury or pathology to the lower limbs in the past 6 months or any medical issue precludes full weight-bearing and ambulation (e.g., orthopedic injuries).
* Diplopia or nystagmus.
* Walking speed from 10MWT \>0.8m/s.


* Medications such as: steroids, benzodiazepines, and neuroleptics. The study doctor will review the medications with the participant.
* clip to repair a cerebral aneurysm (broken blood vessel in the head), cardiac pace-maker, cochlear implants (internal hearing aids) or metal fragments or pieces in the eyes or any other part of the body.
* non MRI compatible metal in any part of the body.
* Medical clearance from a physician that it is medically unsafe to receive regular MRI.
* Engage in the professions of painting or welding or other occupation that prevents me from getting a regular MRI.
* claustrophobia (fear of enclosed spaces).
* History of schizophrenia or bipolar disorder.
Minimum Eligible Age

65 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rutgers University

OTHER

Sponsor Role collaborator

New Jersey Institute of Technology

OTHER

Sponsor Role collaborator

Kessler Foundation

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kiran Karunakaran

Research Scientist, Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kiran Karunakaran

Role: PRINCIPAL_INVESTIGATOR

Kessler Foundation

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kessler Foundation

West Orange, New Jersey, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Kiran Karunakaran, PhD

Role: CONTACT

Phone: 5513583672

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Kiran Karunakaran, PhD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

90IFRE0092

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

R-1276-24

Identifier Type: -

Identifier Source: org_study_id